Related by context. Frequent words. (Click for all words.) 73 Commences Phase 73 Pivotal Phase III 73 Initiates Phase II 73 Presents Positive 72 Phase III Clinical Trial 71 Completes Enrollment 71 Receives Orphan Drug Designation 71 Initiate Phase 70 Clinical Trial Results 69 Pivotal Trial 69 Patient Enrollment 68 Initiates Phase 68 Single Dose 67 Phase III Trial 67 Inc Therapeutic Competitors 67 Pivotal Study 66 Pivotal Phase 66 phase IIb clinical 66 Metastatic Melanoma 65 Kuvan R 65 Preclinical Data 65 anticancer compound 65 Diabetic Macular Edema 65 Locteron ® 65 Tesetaxel 65 Pulmonary Arterial Hypertension 65 Aurexis 65 Chronic Hepatitis C 65 liposomal formulation 65 Transcept Pharmaceuticals 65 refractory chronic lymphocytic 65 Onalta 65 Harbor BioSciences 65 Traficet EN 64 Phase Ib II 64 Nasdaq ADLR 64 HCV protease inhibitor 64 NASDAQ CRXL 64 sodium Injection 64 Inc. Nasdaq IMGN 64 Application MAA 64 NASDAQ DYAX 64 Drug Candidate 64 Announces FDA Clearance 64 Idera Pharmaceuticals 63 NASDAQ LGND 63 HGS ETR2 63 CoFactor 63 MorphoSys AG FSE MOR 63 ongoing Phase 1b 63 forodesine 63 PEG SN# 63 Testim R 63 Pirfenidone 63 Cethromycin 63 FDA Accepts 63 Panzem R 63 candidate brentuximab vedotin 63 drug eluting coronary stent 63 Phenoptin 63 Cetrorelix 63 ALN TTR 62 NVA# 62 Anika Therapeutics 62 Phase IIB 62 phase IIa clinical 62 II Clinical Trial 62 Nasdaq VRTX 62 ZALBIN 62 Genasense R oblimersen 62 Cyclacel Pharmaceuticals 62 Announces Initiation 62 KRN# 62 elotuzumab 62 Entereg R 62 OMS#HP 62 Æterna Zentaris 62 Oscient Pharmaceuticals Corporation 62 R sorafenib tablets 62 Phase Ib clinical 62 RGB # 62 MKC# 62 KNS # 62 Advancing Drugs 62 Daclizumab 62 Amrubicin 62 relapsed refractory multiple myeloma 62 Generic Version 62 multicenter Phase 62 DRRX 62 Bicifadine 62 Sunesis Pharmaceuticals 62 Files Shelf Registration Statement 62 Icatibant 62 Inc. Nasdaq SEPR 62 Recombinant Human 62 Veronate 62 inhaled formulation 62 NASDAQ AEZS 62 Well Tolerated 62 Thiarabine